MED vs RVLV

For growth investors, Revolve Group, Inc.

(RVLV) is the stronger pick with 8. 5% revenue growth year-over-year, versus -36. 0% for Medifast, Inc. (MED). Revolve Group, Inc. (RVLV) offers the better valuation at 23. 5x trailing P/E (22. 0x forward), making it the more compelling value choice. Analysts rate Revolve Group, Inc. (RVLV) a "Buy" — based on 30 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Revolve Group, Inc.

(RVLV) delivered a total return of -61. 0%, compared to -89. 3% for Medifast, Inc. (MED). Over 10 years, the gap is even starker: MED returned +25. 3% versus RVLV's -40. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Medifast, Inc.

(MED) is the lower-risk stock at 0. 94β versus Revolve Group, Inc. 's 1. 81β — meaning RVLV is approximately 93% more volatile than MED relative to the S&P 500. On balance sheet safety, Revolve Group, Inc. (RVLV) carries a lower debt/equity ratio of 6% versus 8% for Medifast, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Revolve Group, Inc.

(RVLV) is pulling ahead at 8. 5% versus -36. 0% for Medifast, Inc. (MED). On earnings-per-share growth, the picture is similar: Revolve Group, Inc. grew EPS 24. 6% year-over-year, compared to -994. 7% for Medifast, Inc.. Over a 3-year CAGR, RVLV leads at 3. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Revolve Group, Inc.

(RVLV) is the more profitable company, earning 5. 0% net margin versus -4. 8% for Medifast, Inc. — meaning it keeps 5. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RVLV leads at 6. 1% versus -3. 7% for MED. At the gross margin level — before operating expenses — MED leads at 71. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for RVLV: 44.

1% to $29. 10.

In this comparison, MED (0.

1% yield) pays a dividend. RVLV does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Medifast, Inc.

(MED) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94)). Revolve Group, Inc. (RVLV) carries a higher beta of 1. 81 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MED: +25. 3%, RVLV: -40. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.